Brindle & Bay Financial Advisors LLC Takes $739,000 Position in Colgate-Palmolive Company $CL

Brindle & Bay Financial Advisors LLC acquired a new stake in Colgate-Palmolive Company (NYSE:CL) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 9,347 shares of the company’s stock, valued at approximately $739,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Sunpointe LLC increased its stake in shares of Colgate-Palmolive by 4.0% in the fourth quarter. Sunpointe LLC now owns 3,056 shares of the company’s stock valued at $241,000 after buying an additional 117 shares during the period. Capital Advisors Inc. OK increased its stake in shares of Colgate-Palmolive by 1.4% in the fourth quarter. Capital Advisors Inc. OK now owns 9,595 shares of the company’s stock valued at $758,000 after buying an additional 129 shares during the period. Stratos Wealth Advisors LLC increased its stake in shares of Colgate-Palmolive by 4.5% in the third quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock valued at $241,000 after buying an additional 130 shares during the period. Chicago Partners Investment Group LLC increased its stake in shares of Colgate-Palmolive by 1.5% in the third quarter. Chicago Partners Investment Group LLC now owns 9,387 shares of the company’s stock valued at $724,000 after buying an additional 136 shares during the period. Finally, Tema Etfs LLC increased its stake in shares of Colgate-Palmolive by 1.2% in the fourth quarter. Tema Etfs LLC now owns 11,997 shares of the company’s stock valued at $948,000 after buying an additional 141 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $84.65 on Friday. The company has a market capitalization of $67.92 billion, a PE ratio of 32.31, a P/E/G ratio of 4.28 and a beta of 0.34. The company has a 50 day simple moving average of $88.79 and a two-hundred day simple moving average of $83.91. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The business had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.91 EPS. Research analysts anticipate that Colgate-Palmolive Company will post 3.85 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be given a dividend of $0.53 per share. The ex-dividend date of this dividend is Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.5%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s payout ratio is currently 80.92%.

Insiders Place Their Bets

In related news, insider John Hazlin sold 20,989 shares of the business’s stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the transaction, the insider owned 17,645 shares in the company, valued at $1,663,041.25. The trade was a 54.33% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Stanley J. Sutula III sold 97,843 shares of the business’s stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the transaction, the chief financial officer owned 55,310 shares in the company, valued at $5,214,073.70. The trade was a 63.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 184,683 shares of company stock valued at $17,486,693 over the last 90 days. 0.43% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

CL has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft raised Colgate-Palmolive from a “hold” rating to a “buy” rating and upped their price objective for the company from $90.00 to $98.00 in a research note on Monday, March 30th. Bank of America lowered their price objective on Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating for the company in a research note on Friday, April 10th. JPMorgan Chase & Co. lowered their price objective on Colgate-Palmolive from $97.00 to $95.00 and set an “overweight” rating for the company in a research note on Friday, April 17th. Piper Sandler lowered their price objective on Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating for the company in a research note on Wednesday, April 8th. Finally, Wall Street Zen downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Sunday, March 29th. Twelve research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average price target of $95.56.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.